论文部分内容阅读
目的:观察心包腔内置管引流并注入顺铂治疗恶性心包积液的临床疗效。方法:回顾性分析对23例恶性心包积液的患者,采用中心静脉导管经皮心包穿刺留置引流心包积液,待充分引流后注入顺铂。结果:所有患者一次穿刺置管引流成功,无严重并发症,完全缓解7例,部分缓解13例,无效3例,总有效率86.95%。23例患者中位生存期为153 d(35～731 d)。结论:心包腔内置管引流并注入顺铂治疗恶性心包积液安全有效,能够改善预后,延长生存,值得临床推广应用。
Objective: To observe the clinical effect of pericardial catheter drainage and cisplatin injection in the treatment of malignant pericardial effusion. Methods: A retrospective analysis of 23 cases of malignant pericardial effusion in patients with central venous catheter percutaneous pericardial drainage catheter drainage drainage, to be fully drained into cisplatin. Results: All the patients were successfully punctured by catheterization in one time. There were no serious complications, complete remission in 7 cases, partial remission in 13 cases and ineffective in 3 cases, the total effective rate was 86.95%. The median survival of 23 patients was 153 days (35 to 731 days). Conclusion: Pericardial catheter drainage and injection of cisplatin in the treatment of malignant pericardial effusion is safe and effective, which can improve prognosis and prolong survival, which is worthy of clinical application.